Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) Invested Capital (2021 - 2025)

Historic Invested Capital for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to $8.2 million.

  • Cardio Diagnostics Holdings' Invested Capital rose 12113.84% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 12113.84%. This contributed to the annual value of $9.6 million for FY2024, which is 22310.3% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Invested Capital is $8.2 million, which was up 12113.84% from $9.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Invested Capital ranged from a high of $11.4 million in Q1 2025 and a low of $24279.0 during Q3 2021
  • Moreover, its 5-year median value for Invested Capital was $4.0 million (2022), whereas its average is $5.2 million.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Invested Capital skyrocketed by 4111235.64% in 2022 and then tumbled by 6527.55% in 2023.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Invested Capital stood at $1.1 million in 2021, then soared by 302.74% to $4.3 million in 2022, then plummeted by 31.23% to $3.0 million in 2023, then surged by 223.1% to $9.6 million in 2024, then decreased by 14.71% to $8.2 million in 2025.
  • Its Invested Capital was $8.2 million in Q3 2025, compared to $9.7 million in Q2 2025 and $11.4 million in Q1 2025.